NCT00005815View on ClinicalTrials.gov

Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 1999

Primary Completion Date

August 31, 2004

Study Completion Date

August 31, 2004

Conditions
Intraocular MelanomaMelanoma (Skin)
Interventions
DRUG

temozolomide

DRUG

thalidomide

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00005815 - Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma | Biotech Hunter | Biotech Hunter